Enochian Biosciences
study strategy companies often the full study to a cro there are large costs associated with layers of project management in this model and risks to meeting regulatory requirements by ceding full control initial estimates based upon prior experience with the full service cro model aggregated to approximately million for the phase i study by adopting a model where assumes more of the project management and parses out responsibility to vendors focusing on their strengths without their overhead costs budget reduced by an estimated while maintaining full control and full service | Enochian Biosciences
Deck date
January 2024
Slide
26 of 28
Related slides by other companies
Investor Presentation
February 2021
Investor Event
August 2007
Investor Presentation
January 2023
Investor Day
September 2018
Other recent decks by Enochian Biosciences
Results
August 2023
Investor Presentation
October 2022
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io